FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616446856> ?p ?o ?g. }

• W2616446856 abstract "Whether metformin precipitates lactic acidosis in patients with chronic kidney disease (CKD) remains under debate. We examined whether metformin use was associated with an increased risk of acute kidney injury (AKI) as a proxy for lactic acidosis and whether survival among those with AKI varied by metformin exposure. All individuals with type 2 diabetes and available prescribing data between 2004 and 2013 in Tayside, Scotland were included. The electronic health record for diabetes which includes issued prescriptions was linked to laboratory biochemistry, hospital admission, death register and Scottish Renal Registry data. AKI events were defined using the Kidney Disease Improving Global Outcomes criteria with a rise in serum creatinine of at least 26.5 μmol/l or a rise of greater than 150% from baseline for all hospital admissions. Cox Regression Analyses were used to examine whether person-time periods in which current metformin exposure occurred were associated with an increased rate of first AKI compared to unexposed periods. Cox regression was also used to compare 28 day survival rates following first AKI events in those exposed to metformin versus those not exposed. Twenty-five thousand one-hundred fourty-eight patients were included with a total person-time of 126,904 person years. 4944 (19.7%) people had at least one episode of AKI during the study period. There were 32.4 cases of first AKI/1000pyrs in current metformin exposed person-time periods compared to 44.9 cases/1000pyrs in unexposed periods. After adjustment for age, sex, diabetes duration, calendar time, number of diabetes drugs and baseline renal function, current metformin use was not associated with AKI incidence, HR 0.94 (95% CI 0.87, 1.02, p = 0.15). Among those with incident AKI, being on metformin at admission was associated with a higher rate of survival at 28 days (HR 0.81, 95% CI 0.69, 0.94, p = 0.006) even after adjustment for age, sex, pre-admission eGFR, HbA1c and diabetes duration. Contrary to common perceptions, we found no evidence that metformin increases incidence of AKI and was associated with higher 28 day survival following incident AKI." @default.
• W2616446856 created "2017-05-26" @default.
• W2616446856 creator A5002074294 @default.
• W2616446856 creator A5005414020 @default.
• W2616446856 creator A5039750697 @default.
• W2616446856 creator A5049374974 @default.
• W2616446856 creator A5055747898 @default.
• W2616446856 creator A5063541240 @default.
• W2616446856 creator A5064568845 @default.
• W2616446856 creator A5072325890 @default.
• W2616446856 creator A5077228809 @default.
• W2616446856 creator A5077595764 @default.
• W2616446856 creator A5082071435 @default.
• W2616446856 creator A5085379485 @default.
• W2616446856 creator A5087143118 @default.
• W2616446856 date "2017-05-19" @default.
• W2616446856 modified "2023-10-06" @default.
• W2616446856 title "Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study" @default.
• W2616446856 cites W1521352086 @default.
• W2616446856 cites W1531432037 @default.
• W2616446856 cites W1893959718 @default.
• W2616446856 cites W1944512145 @default.
• W2616446856 cites W1971783155 @default.
• W2616446856 cites W1978692929 @default.
• W2616446856 cites W1986628483 @default.
• W2616446856 cites W1996578828 @default.
• W2616446856 cites W2005600766 @default.
• W2616446856 cites W2022182182 @default.
• W2616446856 cites W2022248805 @default.
• W2616446856 cites W2050034771 @default.
• W2616446856 cites W2057397568 @default.
• W2616446856 cites W2073417639 @default.
• W2616446856 cites W2073742622 @default.
• W2616446856 cites W2075596754 @default.
• W2616446856 cites W2078512613 @default.
• W2616446856 cites W2087523820 @default.
• W2616446856 cites W2111047373 @default.
• W2616446856 cites W2141199290 @default.
• W2616446856 cites W2143239337 @default.
• W2616446856 cites W2148584151 @default.
• W2616446856 cites W2167639134 @default.
• W2616446856 cites W2168985922 @default.
• W2616446856 cites W2170083003 @default.
• W2616446856 cites W2172193326 @default.
• W2616446856 cites W2188846692 @default.
• W2616446856 cites W2199417652 @default.
• W2616446856 cites W2271771390 @default.
• W2616446856 cites W2288542996 @default.
• W2616446856 cites W2952762910 @default.
• W2616446856 doi "https://doi.org/10.1186/s12882-017-0579-5" @default.
• W2616446856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5437411" @default.
• W2616446856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28526011" @default.
• W2616446856 hasPublicationYear "2017" @default.
• W2616446856 type Work @default.
• W2616446856 sameAs 2616446856 @default.
• W2616446856 citedByCount "62" @default.
• W2616446856 countsByYear W26164468562017 @default.
• W2616446856 countsByYear W26164468562018 @default.
• W2616446856 countsByYear W26164468562019 @default.
• W2616446856 countsByYear W26164468562020 @default.
• W2616446856 countsByYear W26164468562021 @default.
• W2616446856 countsByYear W26164468562022 @default.
• W2616446856 countsByYear W26164468562023 @default.
• W2616446856 crossrefType "journal-article" @default.
• W2616446856 hasAuthorship W2616446856A5002074294 @default.
• W2616446856 hasAuthorship W2616446856A5005414020 @default.
• W2616446856 hasAuthorship W2616446856A5039750697 @default.
• W2616446856 hasAuthorship W2616446856A5049374974 @default.
• W2616446856 hasAuthorship W2616446856A5055747898 @default.
• W2616446856 hasAuthorship W2616446856A5063541240 @default.
• W2616446856 hasAuthorship W2616446856A5064568845 @default.
• W2616446856 hasAuthorship W2616446856A5072325890 @default.
• W2616446856 hasAuthorship W2616446856A5077228809 @default.
• W2616446856 hasAuthorship W2616446856A5077595764 @default.
• W2616446856 hasAuthorship W2616446856A5082071435 @default.
• W2616446856 hasAuthorship W2616446856A5085379485 @default.
• W2616446856 hasAuthorship W2616446856A5087143118 @default.
• W2616446856 hasBestOaLocation W26164468561 @default.
• W2616446856 hasConcept C126322002 @default.
• W2616446856 hasConcept C134018914 @default.
• W2616446856 hasConcept C159641895 @default.
• W2616446856 hasConcept C167135981 @default.
• W2616446856 hasConcept C177713679 @default.
• W2616446856 hasConcept C201903717 @default.
• W2616446856 hasConcept C2777180221 @default.
• W2616446856 hasConcept C2778653478 @default.
• W2616446856 hasConcept C2780306776 @default.
• W2616446856 hasConcept C2780317664 @default.
• W2616446856 hasConcept C2780323712 @default.
• W2616446856 hasConcept C2780472472 @default.
• W2616446856 hasConcept C50382708 @default.
• W2616446856 hasConcept C54847362 @default.
• W2616446856 hasConcept C555293320 @default.
• W2616446856 hasConcept C71924100 @default.
• W2616446856 hasConceptScore W2616446856C126322002 @default.
• W2616446856 hasConceptScore W2616446856C134018914 @default.
• W2616446856 hasConceptScore W2616446856C159641895 @default.
• W2616446856 hasConceptScore W2616446856C167135981 @default.
• W2616446856 hasConceptScore W2616446856C177713679 @default.
• W2616446856 hasConceptScore W2616446856C201903717 @default.

• next